Mason Ashley E, Saslow Laura R, Moran Patricia J, Kim Sarah, Abousleiman Hiba, Richler Robert, Schleicher Samantha, Goldman Veronica M, Hartman Alison, Leung Cindy, Hartogensis Wendy, Hecht Frederick M
1UCSF Department of Psychiatry, Center for Health and Community, San Francisco, CA USA.
2UCSF Osher Center for Integrative Medicine, 1545 Divisadero Street, Suite 301, San Francisco, CA 94115 USA.
Nutr Metab (Lond). 2019 Aug 27;16:58. doi: 10.1186/s12986-019-0383-2. eCollection 2019.
A carbohydrate-restricted (CR) diet can improve glycemic control in people with type 2 diabetes mellitus (T2DM). There are concerns, however, that the high dietary fat content of CR diets can increase low-density lipoprotein cholesterol (LDL-C), thus increasing cardiovascular disease (CVD) risk. Quantifying CVD risk associated with changes in LDL-C in the context of CR diets is complicated by the fact that LDL-C reflects heterogeneous lipids. For example, small LDL particle number (sLDL-P) is more closely associated with CVD risk than is total LDL-C, and CR diets tend to decrease the proportion of sLDL-C in LDL-C, which standard lipid measures do not indicate. Advanced lipoprotein assays, such as nuclear magnetic resonance (NMR) testing, can subfractionate lipoproteins by size and density and may better depict the effects of CR diets on CVD risk.
Adults ( = 58) with T2DM ( = 37 women; baseline HbA1c ≥ 6.5%) completed a 6-month group-based CR diet intervention. We obtained a standard lipid panel, advanced lipoprotein assays (NMR testing), and two 24-h diet recalls at baseline and post-intervention (6 months). Participants also completed home-based blood ketone testing (a biological index of dietary adherence) during the final five weeks of the intervention.
From baseline to post-intervention, participants had increased mean HDL-C, decreased triglycerides and triglyceride/HDL ratio, decreased mean sLDL-P, and increased LDL size, which reflect reductions in CVD risk (s < 0.05). Participants did not have statistically significant changes in total cholesterol, non-HDL-C cholesterol, LDL-P, or HDL-P. Twelve participants (23.1%) had a ≥ 5% increase in sLDL-P. Exploratory analyses revealed that participants with sLDL-P increases of ≥ 5% reported larger increases in servings of red meat than participants without sLDL-P increases of ≥ 5% (+ 0.69 vs - 0.29 servings; = 0.033). Changes in saturated fat intake were not associated with changes in sLDL-P.
Among most participants, we observed changes in several lipid measures consistent with decreased CVD risk. Approximately one in four participants evidenced increases in sLDL-P. Further research should clarify whether individuals with increased sLDL-P after implementing a CR diet can reverse observed increases by limiting red meat consumption.
ClinicalTrials.gov, NCT03207711, Registered 6/11/2017. Retrospectively registered.
碳水化合物限制(CR)饮食可改善2型糖尿病(T2DM)患者的血糖控制。然而,人们担心CR饮食中较高的膳食脂肪含量会增加低密度脂蛋白胆固醇(LDL-C),从而增加心血管疾病(CVD)风险。在CR饮食的背景下,量化与LDL-C变化相关的CVD风险很复杂,因为LDL-C反映的是异质性脂质。例如,小LDL颗粒数(sLDL-P)比总LDL-C与CVD风险的关联更密切,而CR饮食往往会降低LDL-C中sLDL-C的比例,这是标准脂质测量方法所无法显示的。先进的脂蛋白检测方法,如核磁共振(NMR)检测,可以按大小和密度对脂蛋白进行亚分类,可能能更好地描述CR饮食对CVD风险的影响。
患有T2DM的成年人(n = 58,37名女性;基线糖化血红蛋白≥6.5%)完成了为期6个月的基于小组的CR饮食干预。我们在基线和干预后(6个月)获取了标准脂质检测、先进的脂蛋白检测(NMR检测)以及两份24小时饮食回顾。参与者在干预的最后五周还完成了家庭血酮检测(饮食依从性的生物学指标)。
从基线到干预后,参与者的平均高密度脂蛋白胆固醇(HDL-C)升高,甘油三酯和甘油三酯/HDL比值降低,平均sLDL-P降低,LDL大小增加,这反映了CVD风险的降低(P < 0.05)。参与者的总胆固醇、非HDL-C胆固醇、LDL颗粒数(LDL-P)或HDL颗粒数(HDL-P)没有统计学上的显著变化。12名参与者(23.1%)的sLDL-P升高≥5%。探索性分析显示,sLDL-P升高≥5%的参与者报告的红肉摄入量增加幅度大于sLDL-P升高未≥5%的参与者(+0.69份对 -0.29份;P = 0.033)。饱和脂肪摄入量的变化与sLDL-P的变化无关。
在大多数参与者中,我们观察到几种脂质指标的变化与CVD风险降低一致。约四分之一的参与者出现sLDL-P升高。进一步的研究应阐明,实施CR饮食后sLDL-P升高的个体是否可以通过限制红肉消费来逆转所观察到的升高。
ClinicalTrials.gov,NCT03207711,2017年6月11日注册。回顾性注册。